Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Rüdiger, Blindt"'
Autor:
Dirk Enders, Roland Linder, Rafael T. Mikolajczyk, Jonas Czwikla, D Horenkamp-Sonntag, Christoph Ohlmeier, Edeltraut Garbe, Rüdiger Blindt
Publikováno v:
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 59:783-788
Autor:
Rüdiger Blindt, Rainer Hoffmann, Wilhelm Meiners, Vera A. Schulte, Lucas Jauer, Reinhart Poprawe, Christian Flege, Simon Höges, Konrad Wissenbach, Felix Vogt, Mauricio Borinski, Monika Jobmann
Publikováno v:
Journal of Materials Science: Materials in Medicine. 24:241-255
In-stent restenosis is still an important issue and stent thrombosis is an unresolved risk after coronary intervention. Biodegradable stents would provide initial scaffolding of the stenosed segment and disappear subsequently. The additive manufactur
Autor:
Fabian Schreiber, Elisa A. Liehn, Felix Vogt, Christian Flege, Thomas Gries, Mauricio Borinski, Nikolaus Marx, Nicole Krott, Rüdiger Blindt
Publikováno v:
Journal of Biomedical Materials Research Part B: Applied Biomaterials. :2023-2028
Current stent system efficacy for the treatment of coronary artery disease is hampered by in-stent restenosis (ISR) rates of up to 20% in certain high-risk settings and by the risk of stent thrombosis, which is characterized by a high mortality rate.
Autor:
Rainer Hoffmann, Umar Adamu, Felix Vogt, M. Almalla, Rüdiger Blindt, Giadino Nitendo, Verena Deserno
Publikováno v:
Coronary Artery Disease. 21:61-64
Acute occlusion of saphenous vein grafts resulting in acute coronary syndromes may be treated with interventional revascularization. Few data are available on intermediate and long-term results after revascularization of acute saphenous vein graft oc
Publikováno v:
Clinical Research in Cardiology. 98:549-554
A limitation of drug-eluting stent (DES) use to FDA-approved indications has been suggested to reduce the risk of stent thrombosis. This study evaluated predictors of stent thrombosis in clinical practice after the use of drug-eluting as well as bare
Autor:
Christian Weber, Marc A.M.J. Zandvoort, Rainer Hoffmann, Felix Vogt, Nicole Krott, Anja-Katrin Bosserhoff, Malte Kelm, Alma Zernecke, Marie E. Beckner, Thomas Jahnke, Rüdiger Blindt
Publikováno v:
Journal of the American College of Cardiology. 52:302-311
Objectives The aim of this study was to elucidate the role of angio-associated migratory cell protein (AAMP) for the migration of vascular smooth muscle cells (SMCs) and for the development of neointimal hyperplasia after vascular injury. Background
Autor:
Philipp Christott, Hasna Suliman, Rüdiger Blindt, Philipp K. Haager, Rainer Hoffmann, Malte Kelm, Peter W. Radke
Publikováno v:
The American Journal of Cardiology. 101:139-143
Recent studies emphasized the non-lipid-lowering effects of hydroxymethylglutaryl coenzyme A reductase inhibitors on endothelial function, inflammation, and platelet activation in patients with stable atherosclerosis. This study sought to evaluate th
Autor:
Rainer Hoffmann, Ekaterina Stellbrink, Jörg Schröder, Gunter Vogel, Malte Kelm, Rüdiger Blindt, Peter W. Radke, Armin Grawe
Publikováno v:
The American Journal of Cardiology. 100:1347-1352
Patients with metabolic syndrome (MS) are at increased risk for cardiovascular events. Although the number of patients with MS requiring coronary revascularization is increasing rapidly, the impact of MS on clinical events and restenosis in patients
Autor:
Andreas H. Mahnken, Rüdiger Blindt, Joachim E. Wildberger, Georg Mühlenbruch, Marco Das, Ralf Koos, Harald P. Kühl, Rolf W. Günther, Christian Hohl
Publikováno v:
American Journal of Roentgenology. 188:361-369
The objective of our study was to determine the accuracy of 16-MDCT for evaluation of stent patency and in-stent stenosis in venous coronary bypass grafts.Fourteen patients who had previous stent placements in stenosed venous coronary bypass grafts u
Autor:
Eray Yagmur, Rainer Hoffmann, Anita de Taeye, Christian Weber, Malte Kelm, Rüdiger Blindt, R. Müller, Katja Stellbrink, P. Kiefer
Publikováno v:
Thrombosis and Haemostasis. 98:1329-1334
SummaryLow-response to the P2Y12 adenosine diphosphate (ADP)-receptor antagonist clopidogrel was suggested to correspond to a higher incidence of stent thrombosis (ST). This prospective observational study assessed the capability of two platelet func